Empowering Success

Impactful Market
Access Solutions

We help you deliver the right treatment 
to the right patient in the optimal site of care, at the right time and right price

Empowering Success
Passion
We have a passion to ensure patients have access to innovative, life-changing medicines.
Partner
We partner to solve your most critical and complex market access issues.
Committed
We are committed to remove barriers, accelerate adoption, and create lasting, differential value.
Market Access Solutions

Unlocking Success

Market access is vital for rapid uptake and competitive success. Our tailored strategies cut through barriers, ensuring your brand thrives in complex markets. From pricing frameworks to targeted access strategies, we empower your journey to leadership.

Learn More About Our Team
Unlocking Success
Our Work

Elevating Commercial and Market Access Initiatives

Unlocking potential and fostering success, our portfolio showcases a diverse range of impactful projects across commercial and market access domains. Dive into our notable endeavors.

Commercial Analysis and Insights - icon
Commercial Analysis and Insights
Diligence: Led commercial diligence of a novel nasal formulation for severe allergic disease leading to the merger of two biopharma manufacturers.
Forecast and Market Access Recommendations Reviewed and enhanced the global financial forecast and market access assessment for a Phase I biopharma company with a rare kidney disorder therapy which included changes to key assumptions: adoption rate, access, price, and payer management.
Delivery Option Analysis: Assessed whether a recently launched medical benefit medicine should pursue approval and launch of a patient self-administered delivery option within the pharmacy benefit.
Learn More
Value Proposition Creation - icon
Value Proposition Creation
Budget Impact Model: Produced a roadmap for the creation of health economic information inclusive of a published budget impact model for demonstrating the potential payer cost savings and patient benefit for a novel diagnostic test.
Strategy Development - icon
Strategy Development
Pricing Strategy: Evaluated pricing and contracting strategies for an early-stage oncology cell therapy being considered in multiple combinations, tumor types with multiple commercial partners. Recommendations included dosing considerations, indication sequencing, and how different combinations would impact the ability to secure and defend premium pricing.
Distribution and Patient Services Model: Designed the first go-to-market distribution and patient support hub models for an early-stage biopharma company with an ultra-rare disease medicine.
Portfolio Contracting Strategy: Examined the contracting strategy for an established diagnostics company prepared to launch multiple NDCs as they transition from mostly durable medical equipment reimbursement to more coverage in the pharmacy benefit.
Pricing Strategy: Provided strategic and tactical pricing recommendations for a Phase III oncology medicine which included payer engagement strategy recommendations and management of discretionary and mandatory discounts impacting gross-to-net.
Pricing Strategy: Partnered with a commercial stage biopharma company to assess and recommend the best strategies to mitigate misalignment between the established medicine price and value for future indications.
Learn More
Capability Enhancement - icon
Capability Enhancement
Contract Process Optimization: Partnered with a medium-sized rare disease company to review and provide actionable recommendations on how to enhance market access contracting processes, capabilities and scalability in preparation for increased competition.
Market Access Organizational Design: Evaluated and proposed market access organizational design capabilities, headcount, and resources to support the launch of a Phase III oncology medicine.
Market Access Organizational Assessment: Assess and diagnose the current state of a $500M biopharma’s market access infrastructure, strategy, processes, and capabilities. Providing recommendations on how to be best positioned to capitalize on an upcoming, positive, reimbursement change.
Market Access Organizational Assessment: Evaluated and provided recommendations to enhance existing plans for an established diagnostic company that is building a new market access organization.
Learn More
Trusted Partnerships

Building a reputation as a trusted advisor, partner, and commercial resource

At A3Access, we are driven to deliver lasting, differentiated value to your company, key stakeholders, and the patients you serve. Our team of seasoned commercial executives with deep expertise in achieving market access excellence will bring an adaptable approach to meet your unique needs.

Connect Now
image
Your Partner in Ensuring Patient Access to Innovative Medicines.
Our Team